RxDoctor Payments Data

Odalys Rodriguez, APRN

Family · Miami, FLNPI 1770120172

Payments from drug & device makers

$577in general payments, 2019–2025

Across 26 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$405
  • Baxter Healthcare$38
  • Exact Sciences$30
  • Boehringer Ingelheim$28
  • Vertex$27
  • Axsome Therapeutics, Inc.$26
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$577100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$577 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$7,924
Medicare patients
53
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrikaftaElexacaftor/Tezacaftor/Ivacaft32$832,110
ArikayceAmikacin Liposomal/Neb.Accessr40$597,193
ColistimethateColistin (Colistimethate Na)26$16,873
SymbicortBudesonide/Formoterol Fumarate61$15,973
Imipenem-Cilastatin SodiumImipenem/Cilastatin Sodium21$12,594
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$9,954
Breo ElliptaFluticasone/Vilanterol26$9,491
Spiriva RespimatTiotropium Bromide13$7,712
Advair HfaFluticasone Propion/Salmeterol16$5,931
Amikacin Sulfate38$5,442
CefoxitinCefoxitin Sodium13$3,201
BreynaBudesonide/Formoterol Fumarate18$2,984
Mycophenolate Mofetil15$2,752
Albuterol Sulfate HfaAlbuterol Sulfate130$2,193
Clarithromycin17$2,112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
VertexTrikafta$27$832,11032 claims
AstraZenecaSymbicort$23$15,97361 claims
Boehringer IngelheimSpiriva Respimat$28$7,71213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →